ReviewThe American journal of medicine2007
Direct-to-consumer advertising of pharmaceuticals.
Review in The American journal of medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.Health communication · 2020Pooled it
- Effects of Direct-To-Consumer Advertising on Patient Prescription Requests and Physician Prescribing: A Systematic Review of Psychiatry-Relevant Studies.The Journal of clinical psychiatry · 2016Pooled it
- The Effects of Direct-To-Consumer-Advertising on Mental Illness Beliefs and Stigma.Community mental health journal · 2017Trial
- How does direct to consumer advertising affect the stigma of mental illness?Community mental health journal · 2014Trial
- Advertisements impact the physiological efficacy of a branded drug.Proceedings of the National Academy of Sciences of the United States of America · 2013Trial
- Partner randomized controlled trial: study protocol and coaching intervention.BMC pediatrics · 2012Trial
- Amphetamines: a current epidemic.Frontiers in psychiatry · 2025Article
- Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising.Research in social & administrative pharmacy : RSAP · 2021Article
- Improving the reach of clinical practice guidelines: An experimental investigation of message framing on user engagement.Clinical psychological science : a journal of the Association for Psychological Science · 2020Article
- The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors.Patient preference and adherence · 2020Article
- The Main Factors of Induced Demand for Medicine Prescription: A Qualitative Study.Iranian journal of pharmaceutical research : IJPR · 2019Article
- The SMARxT Media Literacy Program: Improving Evidence-Based Prescribing among Medical Students.The journal of media literacy education · 2018Article
- Direct to consumer advertising on websites of Peruvian naturopathic pharmacies.European journal of hospital pharmacy : science and practice · 2017Article
- Characteristics of medication advertisements found in US women's fashion magazines.Health promotion perspectives · 2017Article
- Direct-to-Consumer Prescription Medicine Advertising and Seniors' Knowledge of Alzheimer's Disease.American journal of Alzheimer's disease and other dementias · 2016Article
- Trends in exposure to televised prescription drug advertising, 2003-2011.American journal of preventive medicine · 2015Article
- More Is Not Always Better: Intuitions About Effective Public Policy Can Lead to Unintended Consequences.Social issues and policy review · 2013Article
- Risk Communication and the Pharmaceutical Industry: what is the reality?Drug safety · 2012Article
- An analysis of the warning letters issued by the FDA to pharmaceutical manufacturers regarding misleading health outcomes claims.Pharmacy practice · 2012Article
- Prevalence and Global Health implications of social media in direct-to-consumer drug advertising.Journal of medical Internet research · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Since the US Food and Drug Administration (FDA) released new guidelines on broadcast direct-to-consumer advertising in 1997, the prevalence of direct-to-consumer advertising of prescription drugs has increased exponentially. The impact on providers, patients, and the health care system is varied and dynamic, and the rapid changes in the last several years have markedly altered the health care landscape. To continue providing optimal medical care, physicians and other health care providers must be able to manage this influence on their practice, and a more thorough understanding of this phenomenon is an integral step toward this goal. This review will summarize the history of direct-to-consumer drug advertisements and the current regulations governing them. It will summarize the evidence concerning the impact of direct-to-consumer advertising on the public, providers, and the health care system, and conclude with observations regarding the future of direct-to-consumer advertising.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.